Facts & Figures
The Indiana University Melvin and Bren Simon Cancer Center is the state’s only National Cancer Institute (NCI)-designated cancer center that provides patient care.
First recognized as a NCI-designated cancer center in 1999, the IU Simon Cancer Center’s research expertise is known around the world, offering renewed hope for patients and their families and new options in cancer care.
The IU Simon Cancer Center -- home to world-renowned physician Lawrence Einhorn, M.D., who developed the curative chemotherapy regimen for testis cancer and was instrumental in the approval of cisplatin, etoposide, and ifosfamide by the FDA, and Hal Broxmeyer, Ph.D., who was instrumental in the first umbilical cord stem cell transplant -- also has an international recognition for novel and relevant clinical cancer research which have altered or defined treatment standards. This includes the following:
- Breast cancer
- Gastrointestinal cancer, including pancreatic and colon cancers
- Genitourinary cancer, such as germ cell tumors, bladder, and prostate cancer
- Hematologic disorders, including multiple myeloma and leukemia
- Bone marrow and stem cell transplantation programs at Riley Hospital for Children and Indiana University Health University Hospital
- Thoracic cancer
- Thymoma and thymic carcinoma
Nearly 40,000 outpatients and 4,000 inpatients turn to the IU Simon Cancer Center for cancer care each year, seeking the multidisciplinary team approach pioneered at IU by each of the disease-specific clinical care programs. The team approach combines treatment, research, and supportive care expertise for each patient. With both standards of care and clinical trial options, IU Simon Cancer Center offers diagnostic, treatment, and prevention regimens that meet the unique needs of each individual patient.
Located in the heart of Indianapolis, the IU Simon Cancer Center offers advanced care in modern and comfortable facilities. In late 2008, a $150 million, 405,000-square-feet patient building opened, bringing cancer care together in one location for the convenience of patients. IU Simon Cancer Center physicians will meet the increasing demands for patient care in Indiana with 80 private beds, a 40-chair chemotherapy infusion treatment area, and more. Through its affiliation with the IU Health Proton Therapy Center, the center offers proton radiotherapy as a treatment option for certain cancers.
In the spring of 2009, Joseph E. Walther Hall opened. At 238,000 square feet, it is the largest of the new research facilities at Indiana University with 125 research labs. Walther Hall houses many of the IU Simon Cancer Center researchers.
The IU Simon Cancer Center research physicians and scientists include more than 200 investigators who conduct research in the areas of Experimental and Development Therapeutics, Breast Cancer, Cancer Prevention and Control, and Hematopoiesis, Microenvironment, and Immunology. In addition, IU Simon Cancer Center physicians lead 300 clinical trials for pediatric and adult cancers.
IU Simon Cancer Center established the Indiana Cancer Consortium in collaboration with the American Cancer Society-Great Lakes Division and the Indiana State Department of Health. This statewide network is dedicated to reducing the cancer burden in the state of Indiana through the implementation of a cancer control plan.